<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Exp. Biol. Med.</journal-id>
<journal-title-group>
<journal-title>Experimental Biology and Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Exp. Biol. Med.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1535-3699</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">10793</article-id>
<article-id pub-id-type="doi">10.3389/ebm.2026.10793</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pulmonary injury following exposure to amorphous silicon dioxide nanoparticles in <italic>Golden Syrian Hamsters</italic>
</article-title>
<alt-title alt-title-type="left-running-head">Renda and Cerreta</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/ebm.2026.10793">10.3389/ebm.2026.10793</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Renda</surname>
<given-names>Rachel P.</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3175389"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cerreta</surname>
<given-names>Joseph M.</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>College of Pharmacy and Health Sciences, St. John&#x2019;s University</institution>, <city>Queens</city>, <state>NY</state>, <country country="US">United States</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Joseph M. Cerreta, <email xlink:href="mailto:cerretaj@stjohns.edu">cerretaj@stjohns.edu</email>
</corresp>
<fn fn-type="other" id="fn001">
<label>&#x2020;</label>
<p>ORCID: Rachel P. Renda, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0009-0004-1403-9798">orcid.org/0009-0004-1403-9798</ext-link>; Joseph M. Cerreta, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-0361-3577">orcid.org/0000-0003-0361-3577</ext-link>
</p>
</fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-26">
<day>26</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>251</volume>
<elocation-id>10793</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>08</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Renda and Cerreta.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Renda and Cerreta</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-26">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Amorphous silicon dioxide nanoparticles (SiO<sub>2</sub> NPs) are abundant within the earth&#x2019;s crust and can be released into the air through industrial and manufacturing activities. Such materials are often used in industrial processes, in pharmaceutical and in the cosmetic industries. Amorphous SiO<sub>2</sub> NPs are pulmonary toxicants; however, the mechanism of toxicity is uncertain. In the current study, toxicity of SiO<sub>2</sub> NPs was assessed using inhalation exposure in an <italic>in vivo</italic> system to study a possible mechanism of pulmonary injury. Golden Syrian Hamsters were divided into 4 groups: 1- room air control, 2- vehicle control, 3- low concentration (6&#xa0;mg/m<sup>3</sup>) and 4- high concentration (12&#xa0;mg/m<sup>3</sup>). Hamsters were treated for 4&#xa0;h a day for 8 days. Bronchoalveolar Lavage Fluid (BALF) analysis found increases in total cell counts (p &#x3c; 0.0001), neutrophils (p &#x3c; 0.0001), lymphocytes (p &#x3c; 0.001), eosinophils (p &#x3c; 0.01), multinucleated macrophages (p &#x3c; 0.01), total protein (p &#x3c; 0.0001), alkaline phosphatase (p &#x3c; 0.0001), and lactate dehydrogenase (p &#x3c; 0.001) in the high concentration group. Histopathological analysis found an increase in air space, quantified by Mean Linear Intercept (p &#x3c; 0.0001), and a significant increase in TUNEL positive cells (p &#x3c; 0.001), in the high concentration group. SEM and TEM found structural alterations to the lung tissue including increase in the number holes in the alveolar walls and in apoptotic bodies within tissue. Caspase 3 (p &#x3c; 0.05), and 8 (p &#x3c; 0.05), were significantly increased along with cellular inflammation markers TNF-&#x3b1; (p &#x3c; 0.05), and HSP70 (p &#x3c; 0.05) in the high concentration group. Results of the study indicate exposure to SiO<sub>2</sub> NPs may induce extrinsic apoptotic pathway, leading to tissue damage and significant airspace enlargement.</p>
</abstract>
<kwd-group>
<kwd>apoptosis</kwd>
<kwd>inhalation</kwd>
<kwd>nanoparticles</kwd>
<kwd>pulmonary</kwd>
<kwd>silicon dioxide</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. The research was funded by St. John&#x2019;s University, Queens, NY, United States.</funding-statement>
</funding-group>
<counts>
<fig-count count="9"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="45"/>
<page-count count="14"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Bionanoscience</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Impact statement</title>
<p>Humans are exposed to amorphous SiO<sub>2</sub> nanoparticles, occupationally, every day. There is limited research on the injury caused by inhalation of these materials and with their increasing use. With great focus on crystalline silica inducing silicosis there has been limited research on the amorphous form and its potential for toxicity. Often the amorphous form is deemed safe. This study provides an analysis of injury after exposure to amorphous silicon dioxide nanoparticles and evaluation of an <italic>in vivo</italic> cell death mechanism that may occur when exposed beyond OSHA&#x2019;s limits.</p>
</sec>
<sec sec-type="intro" id="s2">
<title>Introduction</title>
<p>Silica Nanoparticles (NPs) are composed of silicon dioxide (SiO<sub>2</sub>), one of the most abundant compound within the Earth&#x2019;s crust [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>]. Silica exists naturally in a crystalline (quartz) form and in an amorphous form (diatomaceous earth) while amorphous silica can also be synthetically produced in nano-sized forms [<xref ref-type="bibr" rid="B3">3</xref>]. Silica nanoparticles are particularly desirable for use in consumer products, as industrial additives, and in drug delivery because they remain stable over a wide range of temperatures, in organic solvents, and under acidic conditions [<xref ref-type="bibr" rid="B4">4</xref>].</p>
<p>Silica exposure can be harmful for those in an occupational setting, as silicosis is a known occupational disease linked to inhalation of crystalline SiO<sub>2</sub> NPs [<xref ref-type="bibr" rid="B5">5</xref>]. While crystalline silica is widely recognized as the more toxic form of inhaled silica, exploring the effects of exposure to amorphous SiO<sub>2</sub> NPs remains essential, as they are widely used and pose risks to those in an occupational setting [<xref ref-type="bibr" rid="B5">5</xref>].</p>
<p>SiO<sub>2</sub> NPs and various other oxide NPs have been shown to cause pulmonary injury [<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>]. Exposure to crystalline SiO<sub>2</sub> NPs has shown lysosomal disruption, blockage of autophagic flux, ROS generation, and apoptosis [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>]. Mice exposed to amorphous SiO<sub>2</sub> NPs through intratracheal instillation were found to have increased markers of pulmonary inflammation, increased neutrophils, and increased macrophage production of inflammatory mediators [<xref ref-type="bibr" rid="B6">6</xref>]. The current guidelines set by The Occupational Safety and Health Administration&#x2019;s (OSHA) Permissible Exposure Limit (PEL) for exposure to amorphous SiO<sub>2</sub> NPs in an 8-h period is 6&#xa0;mg/m<sup>3</sup>.</p>
<p>Nanoparticles can enter the body through several routes including, ingestion, dermal exposure with the most common pathway being inhalation. To understand the effects in the lungs after exposure to amorphous SiO<sub>2</sub> NPs this study design exposed animals through a full body exposure chamber, as it is most representative of a real-time exposure. Though many inhalation studies expose animals through intratracheal instillation there are advantages to the whole-body exposure method. The whole-body exposure chamber provides a pulmonary response to a typical exposure route with no discomfort to the animal [<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>]. Within the whole-body exposure chamber animals may receive an incidental exposure of NPs via the oral route due to grooming. Kwon et al., found intake of orally ingested SiO2 NPs are excreted in their intact particle form via feces [<xref ref-type="bibr" rid="B12">12</xref>].</p>
<p>The animal model used in the current study was the Golden Syrian Hamster that have been used to study models of pulmonary fibrosis, chronic bronchitis, emphysema and SARS-CoV-2 [<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>].</p>
<p>Apoptosis is a cell death mechanism that has been seen with exposure to crystalline silica [<xref ref-type="bibr" rid="B8">8</xref>]. Apoptosis can be broken into two pathways, an intrinsic mitochondrial-dependent, pathway and an extrinsic death-receptor based pathway [<xref ref-type="bibr" rid="B20">20</xref>]. The mitochondrial dependent intrinsic pathway is triggered by growth factor deprivation and cellular stress. Downstream events include the release of Cytochrome C from the mitochondria, binding to APAF-1 to form the apoptosome, activation of caspase 9 and cleavage of caspase 3 [<xref ref-type="bibr" rid="B21">21</xref>]. The alternate or extrinsic pathway is triggered by extracellular signals that death receptors on the plasma membrane recognize [<xref ref-type="bibr" rid="B21">21</xref>]. Death receptors then recruit adaptor molecules (FAS-associated death domain and TNFRS1A-associated death domain) [<xref ref-type="bibr" rid="B21">21</xref>]. The adaptors activate pro-caspase 8 to form, caspase 8 that then interacts to cleave caspase 3. Caspase 3 executes cell death through apoptosis [<xref ref-type="bibr" rid="B21">21</xref>].</p>
<p>The aim of this study is to explore the resulting injury after exposure to amorphous SiO<sub>2</sub> NPs in Golden Syrian Hamsters. This study hypothesizes that inhaled amorphous SiO<sub>2</sub> at the level of OSHA&#x2019;s PEL (6&#xa0;mg/m<sup>3</sup>) will show minimal pulmonary injury, but inhalation of the higher concentration (12&#xa0;mg/m<sup>3</sup>) will show internalization of amorphous SiO<sub>2</sub> NPs, activation of apoptosis and pulmonary injury to respiratory epithelium.</p>
</sec>
<sec sec-type="materials|methods" id="s3">
<title>Materials and methods</title>
<sec id="s3-1">
<title>Materials</title>
<p>Silicon dioxide nanoparticles were purchased from Nanostructured and Amorphous Materials, Inc. (Katy, TX). Methyl Green and Vectabond&#xae; Reagent were acquired from Vector Laboratories, Inc. (Burlingame, CA). Albumin Standard (2&#xa0;mg/mL), Nanosphere&#x2122; Size Standards, Pierce&#x2122; BCA Protein Assay Kit, Pierce Protease and Phosphatase Inhibitor Mini Tablets, PROTOCOL&#xae; Hema 3&#xae; Stain Set, and Zeta Potential Standard were obtained from Thermo Fisher Scientific (Waltham, MA). ApopTag&#xae; Plus Peroxidase <italic>In Situ</italic> Apoptosis Detection Kit and Proteinase K were obtained from EMD Millipore Corp. (Burlington, MA). Caspase 3, Caspase 8, and Alkaline Phosphatase colorimetric assay kits were obtained from Abcam (Waltham, MA). LDH Cytotoxicity Assay Kit was obtained from Cayman Chemicals Inc., (Cambridge, MA, United States). Lamelli Sample Buffer, Mini-PROTEAN TGX Gels (7.5%, 12%, 4&#x2013;20% and Any KD&#x2122;), nonfat dry milk and Precision Plus Protein Dual Color Standards were purchased from Bio-Rad Laboratories, Inc. (Hercules, CA). MagicMark XP Western Protein Standard was purchased from Invitrogen, Thermo Fisher Scientific (Carlsbad, CA). Amersham ECL Prime Western Blotting Detection Reagents were purchased from Global Life Science Solutions Operations UK Ltd., Cytiva (Buckinghamshire, UK). Antibodies to &#x3b2;-Actin, Caspase 3, 8, 9, and HSP70 were purchased from Cell Signaling Technology, Inc. (Danvers, MA). TNF-&#x3b1; ELISA and Cytochrome C ELISA KIT Abcam (Waltham, MA). Glutaraldehyde was purchased from Electron Microscopy Sciences (Hatfield, PA). Lead nitrate, osmium tetroxide, sodium cacodylate, sodium citrate, and uranyl magnesium acetate were purchased from Ted Pella, Inc. (Redding, CA).</p>
</sec>
<sec id="s3-2">
<title>Methods</title>
<sec id="s3-2-1">
<title>Nanoparticle characterization</title>
<p>The average size of SiO<sub>2</sub> NPs according to the manufacturer was 20&#xa0;nm with a purity of 99%. SiO<sub>2</sub> NPs were directly measured using TEM, by loading particles on a formvar coated copper grid. Nanosphere&#x2122; Size Standards with a mean diameter of 100&#xa0;nm &#xb1; 4&#xa0;nm were used as a calibration standard. TEM micrographs were analyzed using ImageJ software. The mean hydrodynamic diameter of SiO<sub>2</sub> NPs in water was determined by dynamic light scattering (DLS using a Delso Nano C Particle Size Analyzer (Beckman Coulter Inc.). The zeta potential of SiO<sub>2</sub> NPs was measured using the Malvern Zetasizer Nano ZS.</p>
</sec>
<sec id="s3-2-2">
<title>Animals</title>
<p>Female Golden Syrian Hamsters, age 7&#x2013;8&#xa0;weeks were obtained from Envigo (Indianapolis, IN). Animals were housed at St. John&#x2019;s Universities Animal Care Center, Queens, NY, an AAALAC approved facility. Upon arrival animals were given a seven-day acclimation period. Hamsters were kept under a controlled environment with a 12-h light-dark cycle and provided a standard laboratory diet and water <italic>ad libitum</italic>. Animal studies were carried out under an Institutional Animal Care and Use Committee (IACUC) approved protocol. 9 animals per treatment group were used.</p>
</sec>
<sec id="s3-2-3">
<title>Exposure system and experimental design</title>
<p>Studies were carried out using 4 animal groups: room air control (filtered room air), vehicle control (sterile aerosolized water), low concentration SiO<sub>2</sub> NPs (6&#xa0;mg/m<sup>3</sup>) and high concentration SiO<sub>2</sub> NPs (12&#xa0;mg/m<sup>3</sup>). Animals were exposed for 4&#xa0;h a day for 8&#xa0;days in a whole-body exposure chamber. In this repeated exposure model, animals were exposed to a concentration of either 6&#xa0;mg/m<sup>3</sup> or 12&#xa0;mg/m<sup>3</sup> amorphous SiO<sub>2</sub> NPs, continuously over the 4-h exposure period. The concentration of 6&#xa0;mg/m<sup>3</sup> was chosen as it represents the PEL (OSHA) and TWA (NIOSH), 12&#xa0;mg/m<sup>3</sup> was chosen as it is double the regulatory level. The high concentration (12&#xa0;mg/m<sup>3</sup>) was selected to represent approximately twice the current occupational exposure limit for amorphous SiO<sub>2</sub> NPs. This approach intended to examine pulmonary responses that could arise under conditions exceeding regulatory standards, during accidental release or short term over exposures that may occur in occupational settings. This additional exposure concentration provides a dose response relationship relative to the established exposure limit. Animals were euthanized with an overdose of ketamine (800&#xa0;mg/kg) and xylazine (40&#xa0;mg/kg) via an intraperitoneal route 24&#xa0;h after the last exposure.</p>
<p>To form an aerosol, an 8-jet nebulizer (CH Technologies, Inc., NJ) attached to a collision jar was used with air supplied from a compressed air tank. SiO<sub>2</sub> Nanoparticle suspensions were prepared in advance using sterile distilled water and sonicated prior to treatment. To measure the concentration of particles in the chamber air samples were taken every minute and measured for mass aerosol concentration (mg/m<sup>3</sup>) using a NanoScan SMPS 3910 (TSI, Inc., MN).</p>
</sec>
<sec id="s3-2-4">
<title>Analysis of bronchoalveolar lavage fluid (BALF)</title>
<p>Post euthanasia, lungs were lavaged with cold Dulbecco&#x2019;s phosphate buffer saline and the bronchoalveolar lavage fluid (BALF) was collected. BALF was centrifuged and the acellular component was aliquoted out and stored at &#x2212;80&#xa0;&#xb0;C for further use. The cellular component was resuspended with RPMI media and used to determine differential cell counts of leukocytes. Smears of the BALF were prepared using cytocentrifugation and samples spun, dried and stained with PROTOCOL HEMA 3. Cells were counted and categorized as: macrophages, multinucleated macrophages, neutrophils, lymphocytes, and eosinophils. Cell counts were carried out as previously described [<xref ref-type="bibr" rid="B22">22</xref>].</p>
<p>The acellular component of the BALF was analyzed for total protein as measured using the Pierce BCA Protein Assay Kit, LDH and ALP levels using the LDH Colorimetric Assay Kit and Alkaline Phosphatase Colorimetric Kit (Abcam). LDH and ALP release was calculated from the generated standard curves.</p>
</sec>
<sec id="s3-2-5">
<title>Light microscopy</title>
<p>For morphologic examination, following euthanization, lungs were inflated by insufflation with 10% Neutral Buffered Formalin. Fixed tissue was dehydrated, cleared, and embedded in Paraplast X-TRA. Paraffin tissue blocks were sectioned using a microtome. Sections were cut, &#x223c;5 microns thick, placed on glass slides, deparaffinized in xylene and rehydrated in increasing concentrations of ethanol to distilled water. Tissue sections were stained with hematoxylin and eosin, dehydrated in ethanol and cleared with xylene and mounted with cover glass using permount.</p>
</sec>
<sec id="s3-2-6">
<title>Mean linear intercept</title>
<p>Photomicrographs taken of H&#x26;E-stained sections were analyzed for differences in alveolar size by calculating the Mean Linear Intercepts. Mean Linear Intercept was measured by the line intersection method and calculated from 20 random fields of view per animal [<xref ref-type="bibr" rid="B23">23</xref>]. Micrographs were analyzed using ImageJ software.</p>
</sec>
<sec id="s3-2-7">
<title>TUNEL assay</title>
<p>A TUNEL Assay was carried out using the ApopTag&#xae; Plus Peroxidase <italic>In Situ</italic> Apoptosis Detection Kit. Slides were prepared as stated above, deparaffinized, and rehydrated. Tissue sections were pretreated with Proteinase K and washed in distilled water. Slides were then quenched in 3% H<sub>2</sub>O<sub>2</sub> and washed in PBS. The TUNEL Assay protocol (ApopTag&#xae;) was followed as directed by the manufacturer. Photomicrographs of tissue sections were taken, and apoptotic bodies were counted from 20 random fields of view.</p>
</sec>
<sec id="s3-2-8">
<title>Electron microscopy</title>
<p>Alterations to the ultrastructural morphology of the cells and tissue of the lung was evaluated following exposure to silicon dioxide NPs using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). After animals were euthanized, lungs were fixed by insufflation with 3% glutaraldehyde. For SEM, samples following fixation were washed, dehydrated with increasing concentrations of acetone, and dried using the critical point method. Samples were mounted on aluminum stubs, and sputter coated with platinum and palladium. The samples were examined using a scanning electron microscope. For TEM, lung tissue blocks were cut, post-fixed in osmium tetroxide, stained in uranyl acetate, dehydrated in acetone and embedded in LX112-Ardalite resin mixture. Following polymerization, tissue blocks were sectioned and stained with uranyl acetate and lead citrate. Samples were examined using a transmission electron microscope.</p>
</sec>
<sec id="s3-2-9">
<title>Immunoblot analysis</title>
<p>Western blot analysis of Caspase 9, Caspase 8, Caspase 3, and HSP70 were carried out using the Bio-Rad protein guide protocol (Bio-Rad) and the Abcam western blot protocol (Abcam). Lung tissue was collected, washed in DPBS, frozen and stored in liquid nitrogen until use. Lung tissue was homogenized in cold RIPA buffer containing a protease and phosphatase inhibitor cocktail. Total Protein was determined using Pierce BCA Protein Assay Kit. Proteins were denatured and then separated using electrophoresis. Resolved proteins were transferred to a PVDF membrane, blocked in 5% (w/v) non-fat dry milk in Tris Buffered Saline (TBST) for 1&#xa0;h at room temperature or overnight at 4&#xa0;&#xb0;C. TBST washed membranes were incubated with primary antibody for 3&#xa0;h at room temperature or overnight at 4&#xa0;&#xb0;C. All primary antibodies were monoclonal derived from rabbit and an anti-rabbit IgG HRP-linked secondary antibody (1:2000) was used to probe the membranes. The following conditions were used (% SDS PAGE gel, amount of total protein, primary antibody incubation time, blocking time, and antibody dilutions), respectively for Caspase 9 (4&#x2013;20%, 90&#xa0;&#x3bc;g, 3&#xa0;h, overnight, 1:1000), for Caspase 8 (4&#x2013;20%, 90&#xa0;&#x3bc;g, overnight, 1&#xa0;h, 1:1000), for Caspase 3 (any KD&#x2122;, 90&#xa0;&#x3bc;g, overnight, 1&#xa0;h, 1:1000), and for HSP70 (4&#x2013;20%, 90&#xa0;&#x3bc;g, 3&#xa0;h, overnight, 1:1000). &#x3b2;-Actin, used as a loading control, was measured by probing with Anti-IgG B actin (1:5000) and incubated for 1&#xa0;h. After incubation with the secondary antibody (anti-rabbit IgG HRP-linked), chemiluminescence was detected using Amersham&#x2122; ECL&#x2122; Prime Western Blotting Detection Reagent and membranes were photographed using a digital imager. Images were analyzed by densitometry using ImageJ software.</p>
</sec>
<sec id="s3-2-10">
<title>ELISA</title>
<p>TNF-&#x3b1; and Cytochrome C levels were determined in lung samples from control and treated animals using a sandwich ELISA technique kit (TNF-&#x3b1; Rat SimpleStep ELISA&#xae; Kit or Mouse/Rat Cytochrome C SimpleStep ELISA&#xae; Kit, Abcam). Concentration of lung homogenate used was based on manufacturer protocols and provided protocols were followed. Protein levels were calculated from the generated standard curves.</p>
</sec>
<sec id="s3-2-11">
<title>Statistical analysis</title>
<p>Data were presented as the mean &#xb1; SEM. Statistical analyses were carried out using Graph Pad Prism 9 with significance tested among and between groups using one-way analysis of variance (ANOVA) followed by Tukey&#x2019;s Post Hoc analysis. Differences between treated groups were significant at the 95% level (P &#x3c; 0.05) and noted based on the following &#x2a;P &#x3c; 0.05, &#x2a;&#x2a;P &#x3c; 0.01, &#x2a;&#x2a;&#x2a;P &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;P &#x3c; 0.0001. Room air controls did not statistically differ from the vehicle controls; therefore, only vehicle control data are presented in the main figures, with room air control data provided in the <xref ref-type="sec" rid="s12">Supplementary Material</xref>.</p>
</sec>
</sec>
</sec>
<sec sec-type="results" id="s4">
<title>Results</title>
<sec id="s4-1">
<title>Nanoparticle characterization</title>
<p>SiO<sub>2</sub> NPs were characterizing using TEM to determine particle size (<xref ref-type="fig" rid="F1">Figure 1A</xref>), DLS to determine mean hydrodynamic diameter (<xref ref-type="fig" rid="F1">Figure 1B</xref>) and Zeta Potential was measured (<xref ref-type="fig" rid="F1">Figure 1C</xref>). The average individual particle size was measured to be 20&#xa0;nm and had a spherical shape. The mean hydrodynamic diameter was 226&#xa0;nm in water. The Zeta Potential of SiO<sub>2</sub> NPs in water was &#x2212;20&#xa0;mV.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>SiO<sub>2</sub> NPs were characterized by TEM, DLS, and Zeta Potential. <bold>(A)</bold> A TEM micrograph of SiO<sub>2</sub> NPs suspension on a copper coated grid. The micrograph shows single particles (encircled) among particle clumps. Average particle size measured 20&#xa0;nm. <bold>(B)</bold> Representative distribution of particle size in aqueous suspension of amorphous SiO<sub>2</sub> NPs measured using DLS. The average hydrodynamic diameter was measured as 226&#xa0;nm. <bold>(C)</bold> Zeta Potential distribution of amorphous SiO<sub>2</sub> NPs in water was measured as &#x2212;20&#xa0;mV.</p>
</caption>
<graphic xlink:href="ebm-251-10793-g001.tif">
<alt-text content-type="machine-generated">Panel A shows a grayscale transmission electron microscope image of nanoparticles clustered together with a scale of 100 nanometers. Panel B presents a bar graph illustrating the size distribution of nanoparticles with the x-axis labeled as diameter in nanometers and the y-axis as differential intensity percentage, peaking around 226 nanometers. Panel C is a line graph showing the zeta potential distribution of these particles, with the x-axis labeled as apparent zeta potential in millivolts and the y-axis as total counts, peaking near negative 20 millivolts.</alt-text>
</graphic>
</fig>
<sec id="s4-1-1">
<title>BALF analyses</title>
<p>Exposure to SiO<sub>2</sub> NPs resulted in significant increase in total number of cells in the BALF. Cell numbers were increased from 67.9 &#xd7; 10<sup>4</sup> cells/mL in the controls to 119.6 &#xd7; 10<sup>4</sup> cells/mL and 770.1 &#xd7; 10<sup>4</sup> cells/mL in the treated groups (6&#xa0;mg/m<sup>3</sup> and 12&#xa0;mg/m<sup>3</sup> respectively) (<xref ref-type="fig" rid="F2">Figure 2A</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>). Inhalation of SiO<sub>2</sub> NPs did not cause a significant change in macrophages (<xref ref-type="fig" rid="F2">Figure 2B</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>) but led to a significant increase in neutrophils from 4.3 &#xd7; 10<sup>4</sup> cells/mL in controls to 19.4 &#xd7; 10<sup>4</sup> cells/mL in 6&#xa0;mg/m<sup>3</sup> and 648.9 &#xd7; 10<sup>4</sup> cells/mL in 12&#xa0;mg/m<sup>3</sup> (<xref ref-type="fig" rid="F2">Figure 2C</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S2</xref>). Lymphocyte numbers were also significantly increased in the BALF of treated animals as compared to controls. Eosinophils were increased only in the 12&#xa0;mg/m<sup>3</sup> group by 7-fold (<xref ref-type="fig" rid="F2">Figure 2D</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>). The numbers of lymphocytes in the BALF of treated animals were 20-fold higher in 6&#xa0;mg/m<sup>3</sup> and 33-fold higher in 12&#xa0;mg/m<sup>3</sup> (<xref ref-type="fig" rid="F2">Figure 2E</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>). Multi nucleated macrophages were significantly increased by 4-fold in 6&#xa0;mg/m<sup>3</sup> and 5-fold in 12&#xa0;mg/m<sup>3</sup> (<xref ref-type="fig" rid="F2">Figure 2F</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Total Cells and leukocytes in the bronchoalveolar lavage fluid (BALF) of Golden Syrian Hamsters were counted to determine if inflammation was occurring after exposure to inhaled SiO<sub>2</sub> NPs. The cells were re-suspended in 1&#xa0;mL of RPMI media followed by determination of total cell numbers <bold>(A)</bold>. Total Cell numbers <bold>(A)</bold> were significantly increased by 16-fold in the 12&#xa0;mg/m<sup>3</sup> treated group. Differential cell count <bold>(B&#x2013;F)</bold> slide smears were prepared from the BALF of cells from the lung exposed to 6 and 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NPs for 4h/day for 8 days. Macrophages <bold>(B)</bold> of treated groups were not changed when compared to control. Neutrophils <bold>(C)</bold>, Eosinophils <bold>(D)</bold>, Lymphocytes <bold>(E)</bold>, and Multinucleated Macrophages <bold>(F)</bold> were significantly increased in the 12&#xa0;mg/m<sup>3</sup> treated group when compared to control. N &#x3d; 5.</p>
</caption>
<graphic xlink:href="ebm-251-10793-g002.tif">
<alt-text content-type="machine-generated">Bar graphs show cell counts in BALF across different treatments. (A) There is a significant increase in total cell counts in the BALF at 12 mg/m&#xB3;. (B) Macrophages show a significant increase at 12 mg/m&#xB3;. (C) Neutrophils are significantly increased at 12 mg/m&#xB3;. (D) Eosinophils increase significantly at 12 mg/m&#xB3;. (E) Lymphocytes are significantly increased in both experimental groups. (F) Multinucleated macrophages are significantly increased at 6 mg/m&#xB3; and 12 mg/m&#xB3;. Significance levels are marked with asterisks.</alt-text>
</graphic>
</fig>
<p>Total Protein in the BALF was significantly increased from 133 &#xb1; 15&#xa0;&#x3bc;g/mL in the controls to 517 &#xb1; 25&#xa0;&#x3bc;g/mL in the 12&#xa0;mg/m<sup>3</sup> group (<xref ref-type="fig" rid="F3">Figure 3A</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S3</xref>). ALP activity in the BALF was significantly elevated in the 12&#xa0;mg/m<sup>3</sup> group (4.4 &#xb1; 0.6&#xa0;U/&#x3bc;g) when compared to vehicle control (1.3 &#xb1; 0.3&#xa0;U/&#x3bc;g) (<xref ref-type="fig" rid="F3">Figure 3B</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S3</xref>). LDH activity in the BALF was significantly increased in the 12&#xa0;mg/m<sup>3</sup> group (99 &#xd7; 10<sup>&#x2212;3</sup> &#xb1; 29 &#xd7; 10<sup>&#x2212;3</sup>&#xa0;mU/mL), when compared to vehicle control (11 &#xd7; 10<sup>&#x2212;3</sup> &#xb1; 2.9 &#xd7; 10<sup>&#x2212;3</sup>&#xa0;mU/mL) (<xref ref-type="fig" rid="F3">Figure 3C</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Markers measured in the BALF of Golden Syrian Hamsters from lungs exposed to 6 and 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NPs for 4h/day for 8 days were Total Protein (TP) Alkaline Phosphatase (ALP), and Lactate Dehydrogenase (LDH). <bold>(A)</bold> TP, <bold>(B)</bold> ALP), and <bold>(C)</bold> LDH were all significantly increased in the 12&#xa0;mg/m<sup>3</sup> treated group when compared to vehicle control by 4-fold, 9-fold and 3-fold, respectively. N &#x3d; 4.</p>
</caption>
<graphic xlink:href="ebm-251-10793-g003.tif">
<alt-text content-type="machine-generated">Bar graphs labeled A, B, and C show the effects of different concentrations on biomarkers in BALF. Graph A displays total protein levels, graph B shows alkaline phosphatase activity, and graph C features lactate dehydrogenase activity. All markers significantly increase at the higher concentration of 12 mg/m&#xB3; compared to control, indicated by asterisks for statistical significance.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4-2">
<title>Morphological analysis using light and electron microscopy</title>
<sec id="s4-2-1">
<title>Light microscopy and MLI</title>
<p>Lung tissue sections from vehicle control stained with H&#x26;E showed the architecture of parenchyma as seen in (<xref ref-type="fig" rid="F4">Figure 4A</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S4</xref>). Histopathological examination of lung tissue sections exposed to 6&#xa0;mg/m<sup>3</sup> or 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NPs showed increase in average airway space (<xref ref-type="fig" rid="F4">Figures 4B,C</xref>). Air space size seen in all groups was quantified by Mean Linear Intercept. Tissue sections of both low and high concentration treated groups showed a significant increase in the Mean Linear Intercept from &#x223c;44&#xa0;&#x3bc;m in controls to &#x223c;86&#xa0;&#x3bc;m in the 6&#xa0;mg/m<sup>3</sup> treated group and to &#x223c;78&#xa0;&#x3bc;m in the 12&#xa0;mg/m<sup>3</sup> treated group (<xref ref-type="fig" rid="F4">Figure 4D</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>The photomicrographs are of formalin fixed, H&#x26;E-stained tissue sections from the lungs of <bold>(A)</bold> vehicle control (water), <bold>(B)</bold> 6&#xa0;mg/m<sup>3</sup> and <bold>(C)</bold> 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NP treated groups. The micrographs show progressive increase in air space quantified by Mean Linear Intercept <bold>(D)</bold>. Mean Linear Intercept was measured by the line intersection method and calculated from 20 random fields of view per animal. The Mean Linear Intercept of both 6&#xa0;mg/m<sup>3</sup> and 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NP treated animals was significantly increased when compared to vehicle control (water).</p>
</caption>
<graphic xlink:href="ebm-251-10793-g004.tif">
<alt-text content-type="machine-generated">Histological images and a chart are shown. Panel A shows a vehicle control stained lung tissue section. Panel B shows a tissue section treated with 6 mg/m&#xB3;, and Panel C a 12 mg/m&#xB3; treated lung tissue section. Panel D is a bar graph titled &#x201C;Mean Linear Intercept,&#x201D; comparing 6 mg/m&#xB3; and 12 mg/m&#xB3; treated tissue sections to control, showing significant increases denoted by asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s4-2-2">
<title>TUNEL Assay</title>
<p>Histopathological examination of lung tissue sections exposed to 6&#xa0;mg/m<sup>3</sup> and 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NPs showed increase in numbers of apoptotic bodies when compared to control (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S5</xref>). Average TUNEL positive cells in the vehicle control group were less than 1, while average TUNEL positive cells in the 6&#xa0;mg/m<sup>3</sup> group had a mean of 3 TUNEL positive cells and the 12&#xa0;mg/m<sup>3</sup> group was significantly increased with a mean of 4 TUNEL positive cells (<xref ref-type="fig" rid="F5">Figure 5D</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>The photomicrographs are of formalin fixed tissue sections from the lungs of <bold>(A)</bold> vehicle control (water), <bold>(B)</bold> 6&#xa0;mg/m<sup>3</sup> and <bold>(C)</bold> 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NP treated groups. The TUNEL Assay-stained tissue sections for TUNEL positive cells (apoptotic bodies). The micrographs show an increase with increased concentration of NPs with a concomitant increase in the number of apoptotic bodies. Arrows indicate apoptotic bodies. <bold>(D)</bold> A histogram of the count from the TUNEL assays shows a significant increase in TUNEL positive cells in the high concentration SiO<sub>2</sub> NP treated animals compared to vehicle control (water). The average TUNEL positive cells was based on calculated results of 20 random fields of view.</p>
</caption>
<graphic xlink:href="ebm-251-10793-g005.tif">
<alt-text content-type="machine-generated">Histological images labeled A, B, and C show lung tissue with varying degrees of apoptotic staining, using TUNEL assay, indicated by arrows. Panel D displays a bar graph titled &#x201C;TUNEL Assay,&#x201D; showing the average number of TUNEL-positive cells per field of view at 40&#x78; magnification. The graph compares control, 6 mg/m&#xB3;, and 12 mg/m&#xB3; concentrations, with a significant increase in TUNEL positive cells at higher concentrations, denoted by three asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s4-2-3">
<title>Electron microscopy</title>
<p>Scanning Electron Microscopy was carried out to determine surface morphological alterations after exposure to both 6&#xa0;mg/m<sup>3</sup> and 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NPs. Alveoli of vehicle control exposed animals had no pathological changes (<xref ref-type="fig" rid="F6">Figure 6A</xref>). The 12&#xa0;mg/m<sup>3</sup> treated group had a distinct change in morphology, with an increase in holes within the alveolar walls and noticeably thin septa between the alveoli (<xref ref-type="fig" rid="F6">Figure 6B</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Representative scanning electron micrographs (SEM) of lung tissue from control and treated animals fixed in 3% glutaraldehyde and processed as described in methods. <bold>(A)</bold> The photomicrograph is from the lungs of a vehicle control (water) animal that shows typical architecture of the alveoli. <bold>(B)</bold> The lung tissue of an animal treated with 12&#xa0;mg/m<sup>3</sup> shows an atypical architecture of the alveoli with increased holes within the alveoli wall marked by arrows.</p>
</caption>
<graphic xlink:href="ebm-251-10793-g006.tif">
<alt-text content-type="machine-generated">Scanning electron micrographs show two panels labeled A and B. Panel A reveals a porous, fibrous structure with interconnected spaces. Panel B depicts an atypical architecture with visible arrows indicating pores within the alveolar walls. Both images have a scale bar of fifty micrometers.</alt-text>
</graphic>
</fig>
<p>Transmission Electron Microscopy was done to determine ultrastructural cellular alterations after exposure to SiO<sub>2</sub> NPs. Within the interstitial region of the 12&#xa0;mg/m<sup>3</sup> treated animal, apoptotic bodies, chromatin condensation (<xref ref-type="fig" rid="F7">Figures 7A,B</xref>) and possible SiO<sub>2</sub> NPs (<xref ref-type="fig" rid="F7">Figure 7C</xref>) were present. Control and treated animal tissue sections show intact Type II pneumocytes with lamellar bodies and mitochondria (<xref ref-type="sec" rid="s12">Supplementary Figure S6</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Representative transmission electron micrographs (TEM) of lung tissue from control and treated animals fixed in 3% glutaraldehyde and processed as described in methods. TEM photomicrographs of an interstitial region from a 12&#xa0;mg/m<sup>3</sup> treated animal showing <bold>(A)</bold> apoptotic bodies and the presence of collagen, original magnification &#xd7;5,000. <bold>(B)</bold> An enlargement of the region of apoptotic bodies, original magnification &#xd7;20,000. <bold>(C)</bold> An interstitial region showing the presence of collagen and SiO<sub>2</sub> NPs, original magnification &#xd7;20,000. Key: Apoptotic Bodies (Apop), Chromatin Condensation (CC), Collagen (Col), Nanoparticles (NP).</p>
</caption>
<graphic xlink:href="ebm-251-10793-g007.tif">
<alt-text content-type="machine-generated">Electron micrographs showing cellular structures. Image A displays a larger view of a cell with distinct regions labeled, including &#x22;CC&#x22; and &#x22;Apop.&#x22; Image B provides a close-up of these regions, highlighting the same labels. Image C depicts a high-magnification view of another area with labels &#x22;Col&#x22; and &#x22;NP,&#x22; showing detailed cellular textures. The scale bars indicate magnification levels of two micrometers and five hundred nanometers.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s4-2-4">
<title>Protein analysis of apoptosis and related cell markers</title>
<p>Caspase 9 and Cytochrome C levels, both part of the intrinsic apoptotic pathway, were unchanged in either treatment group when compared to control (<xref ref-type="sec" rid="s12">Supplementary Figure S7</xref>). Caspase 8, part of the extrinsic pathway of apoptosis, was not changed in the 6&#xa0;mg/m<sup>3</sup> group, but was significantly increased by 1.4-fold in the 12&#xa0;mg/m<sup>3</sup> treatment group (<xref ref-type="fig" rid="F8">Figure 8A</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S8</xref>). Caspase 3 protein expression was not changed in the 6&#xa0;mg/m<sup>3</sup> group but was significantly increased by 1.4-fold in the 12&#xa0;mg/m<sup>3</sup> treatment group (<xref ref-type="fig" rid="F8">Figure 8B</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S8</xref>). Inflammatory and cellular stress proteins TNF-&#x3b1; and HSP70 were measured. HSP70 levels were not changed in the 6&#xa0;mg/m<sup>3</sup> group but were significantly increased in the 12&#xa0;mg/m<sup>3</sup> group by 7.5-fold (<xref ref-type="fig" rid="F8">Figure 8C</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S8</xref>). TNF-&#x3b1; levels were not changed in the 6&#xa0;mg/m<sup>3</sup> group but were significantly increased in the 12&#xa0;mg/m<sup>3</sup> group by 1.5-fold (<xref ref-type="fig" rid="F8">Figure 8D</xref>; <xref ref-type="sec" rid="s12">Supplementary Figure S8</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>To determine if apoptosis was occurring, Caspases 8, 3, HSP70 and TNF-&#x3b1; were measured via Western Blot or ELISA. <bold>(A)</bold> Caspase 8 and <bold>(B)</bold> Caspase 3 were significantly increased in the 12&#xa0;mg/m<sup>3</sup> treated group when compared to vehicle control (water). <bold>(C)</bold> HSP70, a marker of cellular stress, was measured by Western Blot and was significantly increased in the high concentration group when compared to vehicle control (water). <bold>(D)</bold> An ELISA of TNF-&#x3b1; levels was significantly increased in the high concentration treated group when compared to vehicle control (water). For Western Blots and ELISAs n &#x3d; 4.</p>
</caption>
<graphic xlink:href="ebm-251-10793-g008.tif">
<alt-text content-type="machine-generated">Bar graphs showing the relative protein expression and ELISA of TNF-a across different treatments. (A) Caspase 8 expression increases significantly at 12 mg/m&#xB3;. (B) Caspase 3 expression also rises at 12 mg/m&#xB3;. (C) HSP70 shows elevated expression at 12 mg/m&#xB3;. (D) TNF-a concentration increases significantly at 12 mg/m&#xB3;. Each graph includes a gel image showing corresponding protein bands beneath the bars, with significance marked by an asterisk.</alt-text>
</graphic>
</fig>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="s5">
<title>Discussion</title>
<p>Physical Characterization of a nanoparticle is important as physiochemical factors can alter their toxicity profile and action within a suspension, and the size and shape of a particle can influence its deposition in the lung [<xref ref-type="bibr" rid="B24">24</xref>]. To characterize the particle, the SiO<sub>2</sub> NPs were evaluated for size, aggregation, and zeta potential using transmission electron microscopy (TEM) and dynamic light scattering (DLS). Both wet and dry states of the particle size were evaluated to consider particle-particle and particle-fluid interactions alone and in suspension [<xref ref-type="bibr" rid="B25">25</xref>]. SiO<sub>2</sub> NPs measured by TEM were 20&#xa0;nm while SiO<sub>2</sub> NPs in water had a mean hydrodynamic diameter of 226&#xa0;nm. The apparent increase in size in water may be due to possible agglomeration within the chamber that is a characteristic likely based on the reported hydrodynamic diameter and zeta potential of the nanoparticles [<xref ref-type="bibr" rid="B16">16</xref>]. Agglomeration of particles within a whole-body chamber has been seen in Tungsten NPs when deposited on grids and analyzed by TEM [<xref ref-type="bibr" rid="B16">16</xref>]. The zeta potential of SiO<sub>2</sub> NPs was &#x2212;20&#xa0;mV in water, indicating stability with an anionic charge. Particles with a higher zeta potential have stronger electro-repulsion that can stabilize them preventing aggregation [<xref ref-type="bibr" rid="B26">26</xref>]. Negatively charged particles can easily move across mucus but have a difficult time crossing the cell membrane, often binding to a cell with positively charged surface proteins [<xref ref-type="bibr" rid="B26">26</xref>]. Such properties may inhibit NP cell entry through the cell membrane but may enhance numbers of inflammatory cells in the BALF.</p>
<p>Amorphous SiO<sub>2</sub> NPs were used to induce injury and identify a possible cell death pathway. To mimic real life exposure to SiO<sub>2</sub> NPs a whole-body exposure system was used. The selection of 4&#xa0;h of exposure to SiO<sub>2</sub> NPs per day was based on the OECD Guidelines for acute inhalation toxicity studies [<xref ref-type="bibr" rid="B27">27</xref>]. To study the mechanism of toxicity animals were exposed continuously for 8 consecutive days for 4&#xa0;h per day to either 6&#xa0;mg/m<sup>3</sup> or 12 mg/m3 amorphous SiO<sub>2</sub> NPs, that is consistent with other studies [<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B19">19</xref>]. The concentration of 6&#xa0;mg/m<sup>3</sup> was chosen based on OSHA&#x2019;s Permissible Exposure Limit (PEL) and NIOSH&#x2019;s Time Weighted Average (TWA) for amorphous silicon dioxide. The concentration of 12&#xa0;mg/m<sup>3</sup> was chosen as it is double the set regulatory level, to simulate over exposure events. This additional concentration provides a dose response relationship that helps define a margin of safety relative to the exposure limit. These concentrations may not only capture regulatory relevant, but also high-end exposure scenarios to create a more comprehensive risk characterization.</p>
<p>Following exposure to 12&#xa0;mg/m<sup>3</sup> amorphous SiO<sub>2</sub> NPs total leukocyte counts in the BALF were significantly increased indicating an inflammatory response [<xref ref-type="bibr" rid="B28">28</xref>]. The animal group exposed to 12&#xa0;mg/m<sup>3</sup> had significant increases in total cell counts, neutrophils, lymphocytes, eosinophils, and multinucleated macrophages. A significant increase in cell types other than macrophages indicates an acute inflammatory response at 24&#xa0;h after the last exposure [<xref ref-type="bibr" rid="B28">28</xref>]. Increased neutrophils may have the ability to shift protease/antiprotease balance in the lung leading to tissue injury [<xref ref-type="bibr" rid="B29">29</xref>]. Total Protein (TP), Lactate Dehydrogenase (LDH) and Alkaline Phosphatase (ALP) were all significantly increased in the BALF of the group treated with 12&#xa0;mg/m<sup>3</sup> SiO<sub>2</sub> NPs. Total protein elevations can be attributed to injury of the alveolar-capillary barrier [<xref ref-type="bibr" rid="B30">30</xref>]. Increased LDH, a cytoplasmic enzyme, confirms the loss of cellular membrane integrity with an increased ALP, being a measure of damage to the alveolar epithelium [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B31">31</xref>].</p>
<p>To date, the literature does not report any histologic changes comparable to those observed in this study. Lungs exposed to crystalline silica NPs have shown airway inflammation, collagen deposition and fibrosis [<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>]. Histopathological examination of pulmonary tissue sections in the current study shows damaged alveolar walls with increased airspace size, quantified by Mean Linear Intercept. The observed increase in airspace size is attributed to cell death and subsequent alveolar wall destruction, resembling histologic features of emphysemic lungs [<xref ref-type="bibr" rid="B34">34</xref>]. Lung tissue sections stained using the TUNEL method have a significant increase in TUNEL positive cells present in the 12&#xa0;mg/m<sup>3</sup> treated animal group. Kong et al, (2020) found increase TUNEL positive cells alongside caspase activation to confirm apoptosis occurring in mice [<xref ref-type="bibr" rid="B35">35</xref>].</p>
<p>Destruction of the alveolar septal tissue is a characteristic of emphysema [<xref ref-type="bibr" rid="B36">36</xref>]. Scanning Electron Microscopy (SEM) micrographs of the 12&#xa0;mg/m<sup>3</sup> group show thinning of the interalveolar septa, with increase in holes within the alveolar walls [<xref ref-type="bibr" rid="B37">37</xref>]. Lung sections from TEM images of the 12&#xa0;mg/m<sup>3</sup> treated animals showed, apoptotic bodies, damaged interstitial cells, and SiO<sub>2</sub> NPs. Mitochondria appear unchanged showing tightly packed cristae with parallel alignment, higher matrix density, and visible matrix dense granules as opposed to injured mitochondria that would show increases in intermembrane spaces and shape alterations [<xref ref-type="bibr" rid="B38">38</xref>]. No change to Type I or II pneumocytes was found in the 12&#xa0;mg/m<sup>3</sup> treated animals. Kantari and Walczak [<xref ref-type="bibr" rid="B39">39</xref>] found that the process of caspase 3 cleavage by caspase 8 can be blocked by XIAP (X-linked inhibitor of apoptosis) in Type II pneumocytes, that suggests while apoptosis is occurring in other cells, it may not be occurring in Type II pneumocytes [<xref ref-type="bibr" rid="B39">39</xref>]. This may explain lack of pathology in Type II pneumocytes in the 12&#xa0;mg/m<sup>3</sup> TEM micrographs. Interstitial regions within the 12&#xa0;mg/m<sup>3</sup> treated animals had visible apoptotic bodies with SiO<sub>2</sub> NPs present.</p>
<p>To confirm that the mechanism of apoptosis was activated, Cytochrome C, Caspases 9, 8 and 3 were measured. Cytochrome C and Caspase 9 levels did not change, while Caspases 3, and 8 were significantly increased in the 12&#xa0;mg/m<sup>3</sup> group when compared to controls. Based on the literature crystalline silica has been found to increase Caspase 3, 9 and Cytochrome C release that supports an intrinsic pathway [<xref ref-type="bibr" rid="B40">40</xref>]. Results from the current study suggest an extrinsic pathway of apoptosis is the primary mechanism for cell death occurring after exposure to amorphous SiO<sub>2</sub> NPs. The extrinsic pathway is typically initiated by activation of cell surface receptors. Macrophages and neutrophils present after exposure to SiO<sub>2</sub> NPs will phagocytize the NPs leading to interactions that produce inflammatory factors such as TNF-&#x3b1; [<xref ref-type="bibr" rid="B41">41</xref>]. When TNF-&#x3b1; is released, it can bind to a transmembrane receptor to initiate apoptosis leading to Caspase 8 and eventual Caspase 3 cleavage [<xref ref-type="bibr" rid="B42">42</xref>].</p>
<p>The lack of change in Caspase 9 and Cytochrome C may be attributed to an increase in HSP70, that can block mitochondrial translocation, activation of Bax, and prevent mitochondrial membrane permeabilization, Cytochrome C release, and Caspase 9 cleavage [<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>]. Results from the current study including increased TNF-&#x3b1;, Caspase 3, 8, HSP70 along with no change in Caspase 9 or Cytochrome C levels support both the activation of the extrinsic pathway while eliminating the intrinsic pathway as the mechanism of apoptosis [<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>].</p>
<p>The data from this study suggests that after exposure to amorphous SiO<sub>2</sub> NPs inflammatory cells such as macrophages, neutrophils, eosinophils, and lymphocytes are recruited. As these inflammatory cells are activated, they begin to release cytokines and proteases [<xref ref-type="bibr" rid="B45">45</xref>]. Elastic fibers, that act to maintain alveolar wall integrity, require balance between elastase and anti-elastase, while an imbalance can lead to tissue damage and resulting air space enlargement [<xref ref-type="bibr" rid="B45">45</xref>]. Once activated, neutrophils can release neutrophil elastase (NE), that is normally neutralized by alpha-1-antiprotease (A1AP) [<xref ref-type="bibr" rid="B45">45</xref>]. When inflammation is present the balance between NE and A1AP can be altered leading to destruction of lung tissue by unopposed NE breaking down elastin in the lung septa [<xref ref-type="bibr" rid="B45">45</xref>]. It may be possible that resulting inflammation from exposure to amorphous SiO<sub>2</sub> NPs triggers such an imbalance in protease-antiprotease balance leading to resulting TUNEL positive cells, elevated apoptotic markers, increased airspace (reported by increased MLI) and increased hole size and number within the alveolar walls, along with thinning of the alveolar septa seen in SEM. Damage to lung tissue found in this study is comparable to emphysemic lung architecture, that is reported as abnormal permanent dilation of airspaces [<xref ref-type="bibr" rid="B45">45</xref>].</p>
<p>The current study investigated the toxicity to amorphous SiO<sub>2</sub> NPs in the lungs of Golden Syrian Hamsters. The study found amorphous SiO<sub>2</sub> NPs induce cell death through an extrinsic mechanism of apoptosis. The data from Golden Syrian Hamsters suggest that internalization of amorphous SiO<sub>2</sub> NPs by macrophages and neutrophils may lead to the generation of TNF-&#x3b1;, that will bind to a transmembrane receptor, that in turn will signal the death receptor cleavage of Caspase 8 and Caspase 3 to initiate apoptosis. As this extrinsic mechanism is occurring, HSP70 is acting against the intrinsic pathway, protecting the mitochondrial membrane from permeabilizing. Resulting apoptosis may then allow for hole formation and their enlargement within the alveoli septa, seen in SEM micrographs, which allows mechanical stress to cause alveolar wall breaks, as seen by increased air space size, and quantified by mean linear intercept. <xref ref-type="fig" rid="F9">Figure 9</xref> provides a mechanistic summary.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Schematic representation of the proposed mechanism of injury following exposure to SiO<sub>2</sub> NPs. (1) After exposure to SiO<sub>2</sub> NPs through inhalation, the NPs flow through the respiratory tract until they reach the alveoli where they are met by macrophages and neutrophils and they are phagocytized. During particle overload, and lack of mucociliary clearance, macrophages signal an inflammatory response, cytokines such as HSP70 and TNF-&#x3b1; are released and react, activating cell death receptors (2). TNF-&#x3b1; binds to death receptors transversing the cellular membrane activating procaspase 8 (3) with such recruitment leading to cleavage of caspase 3 (4) and cell death (5).</p>
</caption>
<graphic xlink:href="ebm-251-10793-g009.tif">
<alt-text content-type="machine-generated">Diagram illustrating apoptosis induced by amorphous silicon dioxide nanoparticles involving macrophages and TNF-alpha release. TNF-alpha binds to a receptor activating CASP8, leading to activation of CASP3 and apoptosis. CASP9 pathway is inhibited by HSP70, blocking cytochrome C release from mitochondria. Components are numbered one to five.</alt-text>
</graphic>
</fig>
</sec>
</body>
<back>
<sec sec-type="author-contributions" id="s6">
<title>Author contributions</title>
<p>RR carried out all experimentation. RR and JC designed the experiments and analyzed the data. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7">
<title>Data availability</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s8">
<title>Ethics statement</title>
<p>The animal study was approved by St. John&#x27;s University Institutional Animal Care and Use Committee. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.ebm-journal.org/articles/10.3389/ebm.2026.10793/full#supplementary-material">https://www.ebm-journal.org/articles/10.3389/ebm.2026.10793/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>House</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>House</surname>
<given-names>KA</given-names>
</name>
</person-group>. <article-title>Chapter 12 - silicon, germanium, tin, and lead</article-title>. In: <source>Descriptive inorganic chemistry</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Academic Press is an imprint of Elsevier</publisher-name> (<year>2016</year>). p. <fpage>177</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-804697-5.00012-9</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilton</surname>
<given-names>RFJ</given-names>
</name>
<name>
<surname>Thakur</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Holian</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Silica binding and toxicity in alveolar macrophages</article-title>. <source>Free Radic Biol Med</source> (<year>2008</year>) <volume>44</volume>(<issue>7</issue>):<fpage>1246</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.12.027</pub-id>
<pub-id pub-id-type="pmid">18226603</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mostovenko</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Canal</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Erdely</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Campen</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group> <article-title>Indirect mediators of systemic health outcomes following nanoparticle inhalation exposure</article-title>. <source>Pharmacol Ther</source> (<year>2022</year>) <volume>235</volume>:<fpage>108120</fpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2022.108120</pub-id>
<pub-id pub-id-type="pmid">35085604</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Silica-based nanoparticles: biomedical applications and toxicity</article-title>. <source>Biomed Pharmacother</source> (<year>2022</year>) <volume>151</volume>:<fpage>113053</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2022.113053</pub-id>
<pub-id pub-id-type="pmid">35594717</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costantini</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gilberti</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Knecht</surname>
<given-names>DA</given-names>
</name>
</person-group>. <article-title>The phagocytosis and toxicity of amorphous silica</article-title>. <source>PLOS ONE</source> (<year>2011</year>) <volume>6</volume>(<issue>2</issue>):<fpage>e14647</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0014647</pub-id>
<pub-id pub-id-type="pmid">21311600</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavares</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Libreros</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bitounis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nshimiyimana</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Demokritou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Serhan</surname>
<given-names>CN</given-names>
</name>
<etal/>
</person-group> <article-title>SiO<sub>2</sub> nanoparticles as disruptors of endogenous resolution mechanisms of inflammatory responses that exacerbate pneumonia</article-title>. <source>Sci Rep</source> (<year>2025</year>) <volume>15</volume>(<issue>1</issue>):<fpage>6398</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-025-89700-y</pub-id>
<pub-id pub-id-type="pmid">39984537</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Simaiti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group> <article-title>Silica nanoparticles induce lung inflammation in mice via ROS/PARP/TRPM2 signaling-mediated lysosome impairment and autophagy dysfunction</article-title>. <source>Part Fibre Toxicol</source> (<year>2020</year>) <volume>17</volume>(<issue>1</issue>):<fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/s12989-020-00353-3</pub-id>
<pub-id pub-id-type="pmid">32513195</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iyer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Holian</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages</article-title>. <source>Toxicol Appl Pharmacol</source> (<year>1996</year>) <volume>141</volume>(<issue>1</issue>):<fpage>84</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1006/taap.1996.0263</pub-id>
<pub-id pub-id-type="pmid">8917679</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phalen</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Mannix</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Drew</surname>
<given-names>RT</given-names>
</name>
</person-group>. <article-title>Inhalation exposure methodology</article-title>. <source>Environ Health Perspect</source> (<year>1984</year>) <volume>56</volume>:<fpage>23</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.845623</pub-id>
<pub-id pub-id-type="pmid">6383799</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Vrijhof</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pulinckx</surname>
<given-names>S</given-names>
</name>
</person-group>. <source>Technical report no. 122. Poorly soluble particles/lung overload &#x2013; ECETOC</source>. <publisher-name>Brussels: ECETOC</publisher-name> (<year>2021</year>). <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ecetoc.org/publication/tr-122-poorly-soluble-particles-lung-overload/">https://www.ecetoc.org/publication/tr-122-poorly-soluble-particles-lung-overload/</ext-link> (Accessed July 30, 2025).</comment>
</mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oyabu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yoshiura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tomonaga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BW</given-names>
</name>
<etal/>
</person-group> <article-title>Comparison between whole-body inhalation and nose-only inhalation on the deposition and health effects of nanoparticles</article-title>. <source>Environ Health Prev Med</source> (<year>2015</year>) <volume>21</volume>(<issue>1</issue>):<fpage>42</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s12199-015-0493-z</pub-id>
<pub-id pub-id-type="pmid">26438563</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>Youn</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>Oral excretion kinetics of food-additive silicon dioxides and their effect on <italic>in vivo</italic> macrophage activation</article-title>. <source>Int J Mol Sci</source> (<year>2024</year>) <volume>25</volume>:<fpage>1614</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3390/ijms25031614</pub-id>
<pub-id pub-id-type="pmid">38338896</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayes</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Snider</surname>
<given-names>GL</given-names>
</name>
</person-group>. <article-title>The hamster as a model of chronic bronchitis and emphysema in man</article-title>. <source>Lab Anim Sci</source> (<year>1977</year>) <volume>27</volume>(<issue>5 Pt 2</issue>):<fpage>762</fpage>&#x2013;<lpage>70</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/592728">https://pubmed.ncbi.nlm.nih.gov/592728</ext-link> (Accessed July 30, 2025).</comment>
<pub-id pub-id-type="pmid">592728</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakashima</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Giri</surname>
<given-names>SN</given-names>
</name>
</person-group>. <article-title>Repeated exposures to enzyme-generated oxidants cause alveolitis, epithelial hyperplasia, and fibrosis in hamsters</article-title>. <source>Am J Pathol</source> (<year>1991</year>) <volume>139</volume>(<issue>6</issue>):<fpage>1485</fpage>&#x2013;<lpage>99</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/1750514">https://pubmed.ncbi.nlm.nih.gov/1750514</ext-link> (Accessed July 30, 2025).</comment>
<pub-id pub-id-type="pmid">1750514</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bijlani</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Sukhija</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Cerreta</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Pulmonary inflammation induced by single walled carbon nanotubes in golden Syrian hamsters</article-title>. <source>J Anal Pharm Res</source> (<year>2016</year>) <volume>2</volume>(<issue>3</issue>):<fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.15406/japlr.2016.02.00021</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prajapati</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Adebolu</surname>
<given-names>OO</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Cerreta</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Evaluation of pulmonary response to inhaled tungsten (IV) oxide nanoparticles in golden Syrian hamsters</article-title>. <source>Exp Biol Med</source> (<year>2016</year>) <volume>242</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1177/1535370216665173</pub-id>
<pub-id pub-id-type="pmid">27534980</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michita</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Mysorekar</surname>
<given-names>IU</given-names>
</name>
</person-group>. <article-title>Golden Syrian hamsters as a model for revisiting the role of biological sex differences in SARS-CoV-2 infection</article-title>. <source>mBio</source> (<year>2021</year>) <volume>12</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.01848-21</pub-id>
<pub-id pub-id-type="pmid">34809458</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bednash</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kagan</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Englert</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Farkas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tyurina</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Tyurin</surname>
<given-names>VA</given-names>
</name>
<etal/>
</person-group> <article-title>Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: pathologic, physiologic, and detailed molecular profiling</article-title>. <source>Transl Res</source> (<year>2021</year>) <volume>240</volume>:<fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.trsl.2021.10.007</pub-id>
<pub-id pub-id-type="pmid">34740873</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huber</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Cerreta</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Mechanisms of cell injury induced by inhaled molybdenum trioxide nanoparticles in golden Syrian hamsters</article-title>. <source>Exp Biol Med</source> (<year>2022</year>) <volume>247</volume>(<issue>23</issue>):<fpage>2067</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1177/15353702221104033</pub-id>
<pub-id pub-id-type="pmid">35757989</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lomphithak</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fadeel</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Die hard: cell death mechanisms and their implications in nanotoxicology</article-title>. <source>ToxicolSciences</source> (<year>2023</year>) <volume>192</volume>(<issue>2</issue>):<fpage>141</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfad008</pub-id>
<pub-id pub-id-type="pmid">36752525</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ketelut-Carniero</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>KA</given-names>
</name>
</person-group>. <article-title>Apoptosis, pyroptosis, and necroptosis&#x2014;oh my! the many ways a cell can die</article-title>. <source>J Mol Biol</source> (<year>2022</year>) <volume>434</volume>(<issue>4</issue>):<fpage>167378</fpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2021.167378</pub-id>
<pub-id pub-id-type="pmid">34838807</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harbeck</surname>
<given-names>RJ</given-names>
</name>
</person-group>. <article-title>Immunophenotyping of bronchoalveolar lavage lymphocytes</article-title>. <source>Clin Diagnos Labor Immunol</source> (<year>1998</year>) <volume>5</volume>(<issue>3</issue>):<fpage>271</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1128/CDLI.5.3.271-277.1998</pub-id>
<pub-id pub-id-type="pmid">9605975</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crowley</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Caraher</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Haider</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Quantitative lung morphology: semi-automated measurement of mean linear intercept</article-title>. <source>BMC Pulm Med</source> (<year>2019</year>) <volume>19</volume>(<issue>1</issue>):<fpage>206</fpage>. <pub-id pub-id-type="doi">10.1186/s12890-019-0916-6</pub-id>
<pub-id pub-id-type="pmid">31706309</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>BI</given-names>
</name>
<name>
<surname>Pak</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>E-K</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H-S</given-names>
</name>
<etal/>
</person-group> <article-title>Rod-shaped iron oxide nanoparticles are more toxic than sphere-shaped nanoparticles to murine macrophage cells</article-title>. <source>Environ Toxicol Chem</source> (<year>2014</year>) <volume>33</volume>(<issue>12</issue>):<fpage>2759</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1002/etc.2735</pub-id>
<pub-id pub-id-type="pmid">25176020</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deloid</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pyrgiotakis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Demokritou</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Interactions of engineered nanomaterials in physiological media and implications for <italic>in vitro</italic> dosimetry</article-title>. <source>Nanotoxicology</source> (<year>2013</year>) <volume>7</volume>(<issue>4</issue>):<fpage>417</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.3109/17435390.2012.666576</pub-id>
<pub-id pub-id-type="pmid">22393878</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xd6;zt&#xfc;rk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Calis</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Effects of nanoparticle size, shape, and zeta potential on drug delivery</article-title>. <source>Intl J Pharm</source> (<year>2024</year>) <volume>666</volume>:<fpage>124799</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2024.124799</pub-id>
<pub-id pub-id-type="pmid">39369767</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="book">
<source>Test no. 403: acute inhalation toxicity</source>. <publisher-name>Paris: OECD</publisher-name>. (<year>2024</year>). <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.oecd.org/en/publications/2009/09/test-no-403-acute-inhalation-toxicity_g1gh2927.html">https://www.oecd.org/en/publications/2009/09/test-no-403-acute-inhalation-toxicity_g1gh2927.html</ext-link> (Accessed August 14, 2025).</comment>
</mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinvias</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Selvam</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>PN</given-names>
</name>
</person-group>. <article-title>Acute inhalation toxicity of cerium oxide nanoparticles in rats</article-title>. <source>Toxicol Lett</source> (<year>2011</year>) <volume>205</volume>(<issue>2</issue>):<fpage>105</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2011.05.1027</pub-id>
<pub-id pub-id-type="pmid">21624445</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quint</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Wedzicha</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>The neutrophil in chronic obstructive pulmonary disease</article-title>. <source>J Allergy Clin Immunol</source> (<year>2007</year>) <volume>119</volume>(<issue>5</issue>):<fpage>1065</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2006.12.640</pub-id>
<pub-id pub-id-type="pmid">17270263</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huaux</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Moreau</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mission</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Heilier</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Delos</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Respiratory toxicity of multi-wall carbon nanotubes</article-title>. <source>Toxicol Appl Pharmacol</source> (<year>2005</year>) <volume>207</volume>(<issue>3</issue>):<fpage>221</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2005.01.008</pub-id>
<pub-id pub-id-type="pmid">16129115</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lusuardi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cerutti</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Donner</surname>
<given-names>CF</given-names>
</name>
</person-group>. <article-title>Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders</article-title>. <source>Am J Respir Crit Care Med</source> (<year>1997</year>) <volume>155</volume>(<issue>1</issue>):<fpage>249</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.155.1.9001320</pub-id>
<pub-id pub-id-type="pmid">9001320</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Protective effects of intranasal curcumin on silica-induced lung damage</article-title>. <source>Cytokine</source> (<year>2022</year>) <volume>157</volume>:<fpage>155949</fpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2022.155949</pub-id>
<pub-id pub-id-type="pmid">35764024</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ban</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Macrophage-derived exosomal lncRNA MSTRG.91634.7 inhibits fibroblasts activation by targeting PINK1 in silica-induced lung fibrosis</article-title>. <source>Toxicol Lett</source> (<year>2023</year>) <volume>372</volume>:<fpage>36</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2022.10.004</pub-id>
<pub-id pub-id-type="pmid">36309172</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Augusti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cos&#xed;o</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Chronic obstructive pulmonary disease &#x7c; emphysema, general</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Laurent</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>S</given-names>
</name>
</person-group>, editors. <source>Encyclopedia of respiratory medicine</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2006</year>). p. <fpage>448</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/B0-12-370879-6/00074-0</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X</given-names>
</name>
</person-group>. <article-title>Protective effect of dexmedetomidine on acute lung injury <italic>via</italic> the upregulation of tumour necrosis factor-&#x3b1;-induced protein-8-like 2 in septic mice</article-title>. <source>Inflammation</source> (<year>2020</year>) <volume>43</volume>(<issue>3</issue>):<fpage>833</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-019-01169-w</pub-id>
<pub-id pub-id-type="pmid">31927655</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vlahovic</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Mercer</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Crapo</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>Cellular and connective tissue changes in alveolar septal walls in emphysema</article-title>. <source>Am J Respir Crit Care Med</source> (<year>1999</year>) <volume>160</volume>(<issue>6</issue>):<fpage>2086</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.160.6.9706031</pub-id>
<pub-id pub-id-type="pmid">10588633</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Congiu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Demontis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Piras</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fanni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Geroasa</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Scanning electron microscopy of lung disease due to COVID-19 - a case report and a review of the literature</article-title>. <source>Eur Rev Medi Pharmacol Sci</source> (<year>2021</year>) <volume>25</volume>(<issue>24</issue>):<fpage>7997</fpage>&#x2013;<lpage>8003</lpage>. <pub-id pub-id-type="doi">10.26355/eurrev_202112_27650</pub-id>
<pub-id pub-id-type="pmid">34982463</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado-Buenrostro</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Freyre-Fonseca</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Cu&#xe9;llar</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>S&#xe1;nchez-P&#xe9;rez</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gutierrez-Cirlos</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Cabellos-Avelar</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>Decrease in respiratory function and electron transport chain induced by airborne particulate matter (PM10) exposure in lung mitochondria</article-title>. <source>Toxicol Pathol</source> (<year>2013</year>) <volume>41</volume>(<issue>4</issue>):<fpage>628</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1177/0192623312463784</pub-id>
<pub-id pub-id-type="pmid">23104767</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kantari</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Walczak</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Caspase-8 and bid: caught in the act between death receptors and mitochondria</article-title>. <source>Biochim Biophys Acta</source> (<year>2011</year>) <volume>1813</volume>(<issue>4</issue>):<fpage>558</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2011.01.026</pub-id>
<pub-id pub-id-type="pmid">21295084</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahamed</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells</article-title>. <source>Hum Exp Toxicol</source> (<year>2013</year>) <volume>32</volume>(<issue>2</issue>):<fpage>186</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1177/0960327112459206</pub-id>
<pub-id pub-id-type="pmid">23315277</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medrano-Bosch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moreno-Lanceta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Melgar-Lesmes</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Nanoparticles to target and treat macrophages: the Ockham&#x2019;s concept?</article-title> <source>Pharmaceutics</source> (<year>2021</year>) <volume>13</volume>(<issue>9</issue>):<fpage>1340</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics13091340</pub-id>
<pub-id pub-id-type="pmid">34575416</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guicciardini</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Gores</surname>
<given-names>GJ</given-names>
</name>
</person-group>. <article-title>Life and death by death receptors</article-title>. <source>FASEB J</source> (<year>2009</year>) <volume>23</volume>(<issue>6</issue>):<fpage>1625</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1096/fj.08-111005</pub-id>
<pub-id pub-id-type="pmid">19141537</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stankiewicz</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Lachapelle</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Foo</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Radicioni</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Mosser</surname>
<given-names>DD</given-names>
</name>
</person-group>. <article-title>Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing bax translocation</article-title>. <source>J Biol Chem</source> (<year>2005</year>) <volume>280</volume>(<issue>46</issue>):<fpage>38729</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M509497200</pub-id>
<pub-id pub-id-type="pmid">16172114</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Hsp70 promotes chemoresistance by blocking bax mitochondrial translocation in ovarian cancer cells</article-title>. <source>Cancer Lett</source> (<year>2012</year>) <volume>321</volume>(<issue>2</issue>):<fpage>137</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2012.01.030</pub-id>
<pub-id pub-id-type="pmid">22281241</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Pahal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Avula</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Afzal</surname>
<given-names>M</given-names>
</name>
</person-group>. <source>Emphysema</source>. <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name> (<year>2025</year>). <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK482217/#">https://www.ncbi.nlm.nih.gov/books/NBK482217/&#x23;</ext-link> (Accessed August 14, 2025).</comment>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>